» Articles » PMID: 31984438

First-trimester Fasting Glycemia As a Predictor of Gestational Diabetes (GDM) and Adverse Pregnancy Outcomes

Overview
Journal Acta Diabetol
Specialty Endocrinology
Date 2020 Jan 28
PMID 31984438
Citations 25
Authors
Affiliations
Soon will be listed here.
Abstract

Aims: Studies to prevent gestational diabetes (GDM) have shown the best results when lifestyle measures have been applied early in pregnancy. We aimed to investigate whether first-trimester fasting plasma glucose (FPG) could predict GDM risk and adverse pregnancy outcomes.

Methods: A retrospective analysis of prospectively collected data from singleton pregnancies who were attended at our hospital between 2008 and 2018 (n = 27,198) was performed. We included patients with a recorded first-trimester FPG and complete pregnancy data (n = 6845). Patients under 18, with pregestational diabetes or reproductive techniques, were excluded. First-trimester FPG was evaluated as a continuous variable and divided into quartiles. GDM was diagnosed by NDDG criteria. The relationship between first- and second-trimester glucose > 92 mg/dL was also investigated. The relationship between FPG and pregnancy outcomes was assessed in 6150 patients who did not have GDM.

Results: Maternal age was 34.2 ± 3.9 years, BMI 23.1 ± 3.7 kg/m and mean FPG 83.0 ± 7.3 mg/dL. Glucose quartiles were: ≤ 78, 79-83, 84-87 and ≥ 88 mg/dL. First-trimester FPG predicted the risk of GDM (7%, 8%, 10.2% and 16% in each quartile, p < 0.001) and the risk of second-trimester glucose > 92 mg/dL (2.6%, 3.8%, 6.3% and 11.4% in each quartile, p < 0.001). FPG was significantly associated with LGA (8.2%, 9.3%, 10% and 11.7% in each quartile, p = 0.011) but not with other obstetrical outcomes. In a multivariate analysis including age, BMI, tobacco use, number of pregnancies and weight gained during pregnancy, first-trimester FPG was an independent predictor of LGA.

Conclusions: First-trimester FPG is an early marker of GDM and LGA.

Citing Articles

The Link Between Newborn SNP Polymorphism rs266729, Adiponectin, and Newborn Macrosomia in a Cohort of Pregnant Women with Gestational Diabetes Mellitus: A Case-Control Pilot Study.

Muntean M, Marginean C, Bernad E, Banescu C, Nyulas V, Muntean I Children (Basel). 2025; 12(2).

PMID: 40003257 PMC: 11854160. DOI: 10.3390/children12020155.


Universal screening for hyperglycemia in early pregnancy and the risk of adverse pregnancy outcomes.

Shen L, Zhang S, Wen J, Liu J, Lin X, Zhu C BMC Pregnancy Childbirth. 2025; 25(1):203.

PMID: 40001063 PMC: 11863529. DOI: 10.1186/s12884-025-07253-4.


A nomogram for predicting the risk of fetal growth restriction in singleton pregnancies with subchorionic hematomas detected in first trimester.

Lou Y, Chen G, Wang L, Zhao X, Ma J BMC Pregnancy Childbirth. 2025; 25(1):144.

PMID: 39934694 PMC: 11816570. DOI: 10.1186/s12884-025-07241-8.


Predictive Utility of Biochemical Markers for the Diagnosis and Prognosis of Gestational Diabetes Mellitus.

Inthavong S, Jatavan P, Tongsong T Int J Mol Sci. 2024; 25(21).

PMID: 39519218 PMC: 11545977. DOI: 10.3390/ijms252111666.


Prediction of gestational diabetes mellitus by multiple biomarkers at early gestation.

Yang M, Zhang L, Wang W, Huang R, He H, Zheng T BMC Pregnancy Childbirth. 2024; 24(1):601.

PMID: 39285345 PMC: 11406857. DOI: 10.1186/s12884-024-06651-4.


References
1.
Albareda M, Caballero A, Badell G, Piquer S, Ortiz A, DE Leiva A . Diabetes and abnormal glucose tolerance in women with previous gestational diabetes. Diabetes Care. 2003; 26(4):1199-205. DOI: 10.2337/diacare.26.4.1199. View

2.
Duran A, Saenz S, Torrejon M, Bordiu E, Valle L, Galindo M . Introduction of IADPSG criteria for the screening and diagnosis of gestational diabetes mellitus results in improved pregnancy outcomes at a lower cost in a large cohort of pregnant women: the St. Carlos Gestational Diabetes Study. Diabetes Care. 2014; 37(9):2442-50. DOI: 10.2337/dc14-0179. View

3.
Corcoy R, Lumbreras B, Bartha J, Ricart W . [New diagnostic criteria for gestational diabetes mellitus after the HAPO study. Are they valid in our environment?]. Gac Sanit. 2010; 24(4):361-3. DOI: 10.1016/j.gaceta.2010.03.007. View

4.
Long H, Cundy T . Establishing consensus in the diagnosis of gestational diabetes following HAPO: where do we stand?. Curr Diab Rep. 2012; 13(1):43-50. DOI: 10.1007/s11892-012-0330-3. View

5.
Koivusalo S, Rono K, Klemetti M, Roine R, Lindstrom J, Erkkola M . Gestational Diabetes Mellitus Can Be Prevented by Lifestyle Intervention: The Finnish Gestational Diabetes Prevention Study (RADIEL): A Randomized Controlled Trial. Diabetes Care. 2015; 39(1):24-30. DOI: 10.2337/dc15-0511. View